微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
E7080 (Lenvatinib)是一种多激酶抑制剂，可同时抑制VEGFR2和VEGFR3激酶。
Targets
| Target | Value |
|---|---|
| VEGFR2/KDR | IC50: 4.0nM |
| VEGFR3/FLT4 | IC50: 5.2nM |
| VEGFR1/FLT1 | IC50: 22nM |
| PDGFRβ | IC50: 39nM |
| FGFR1 | IC50: 46nM |
| PDGFRα | IC50: 51nM |
| Kit | IC50: 100nM |
| EphB4 | IC50: >10μM |
| IGF-1R | IC50: >10μM |
| Insulin Receptor | IC50: >10μM |
| Src | IC50: >10μM |
| Akt1 | IC50: >10μM |
| CDK4/CyclinD | IC50: >10μM |
| PLK1 | IC50: >10μM |
| FAK | IC50: >10μM |
| PKCα | IC50: >10μM |
| In vitro (25°C) | DMSO | Warmed: 35 mg/mL (81.99 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 0.5% methylcellulose | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.42 mL | 117.12 mL | 234.25 mL |
| 0.5 mM | 4.68 mL | 23.42 mL | 46.85 mL |
| 1 mM | 2.34 mL | 11.71 mL | 23.42 mL |
| 5 mM | 0.47 mL | 2.34 mL | 4.68 mL |
*The above data is based on the productmolecular weight 426.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10340 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 426.9 |
| Formula | C21H19ClN4O4 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 417716-92-8 |
| Synonyms | E-7080 |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl |
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
Brivanib (BMS-540215)
Brivanib (BMS-540215)是一种VEGFR-2抑制剂，IC50为25 nM，Ki为26 nM。
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1，VEGFR-2，VEGFR-3，PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂，可阻…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂，抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6，0.1和0.1 μM。
Raf265 derivative
Raf265 derivative是Raf265的衍生物，Raf265是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，IC50为5至10μM。
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂，可同时抑制三种生长因子受体：VEGFR，PDGF和FGFR。
Keywords:购买 E7080 (Lenvatinib) | E7080 (Lenvatinib) 供应商 | 订购 E7080 (Lenvatinib) | E7080 (Lenvatinib) 价格 | E7080 (Lenvatinib) 生产商 | 订单 E7080 (Lenvatinib) | E7080 (Lenvatinib) 代理商 | 购买 417716-92-8| 417716-92-8 供应商 | 订购 417716-92-8 | 417716-92-8 价格 | 417716-92-8 生产商 | 订单 417716-92-8 | 417716-92-8 代理商|buy E7080 (Lenvatinib) | E7080 (Lenvatinib) Supplier | purchase E7080 (Lenvatinib) | E7080 (Lenvatinib) cost | E7080 (Lenvatinib) manufacturer | order E7080 (Lenvatinib) | E7080 (Lenvatinib) distributor | buy 417716-92-8| 417716-92-8 Supplier | purchase 417716-92-8 | 417716-92-8 cost | 417716-92-8 manufacturer | order 417716-92-8 | 417716-92-8 distributor